PL367702A1 - Kombinacja taksanu i cyklino-zależnej kinazy - Google Patents

Kombinacja taksanu i cyklino-zależnej kinazy

Info

Publication number
PL367702A1
PL367702A1 PL02367702A PL36770202A PL367702A1 PL 367702 A1 PL367702 A1 PL 367702A1 PL 02367702 A PL02367702 A PL 02367702A PL 36770202 A PL36770202 A PL 36770202A PL 367702 A1 PL367702 A1 PL 367702A1
Authority
PL
Poland
Prior art keywords
taxane
cyclin
combination
dependent kinase
kinase
Prior art date
Application number
PL02367702A
Other languages
English (en)
Other versions
PL206118B1 (pl
Inventor
Marie-Christine Bissery
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of PL367702A1 publication Critical patent/PL367702A1/pl
Publication of PL206118B1 publication Critical patent/PL206118B1/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/453Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL367702A 2001-03-23 2002-03-22 Kombinacja farmaceutyczna wykazująca synergizm terapeutyczny in vivo w leczeniu chorób nowotworowych PL206118B1 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US27794801P 2001-03-23 2001-03-23
US30269201P 2001-07-05 2001-07-05
US33491601P 2001-12-04 2001-12-04
PCT/EP2002/004083 WO2002076484A2 (en) 2001-03-23 2002-03-22 Combination of a taxane and a cyclin-dependent kinase inhibitor

Publications (2)

Publication Number Publication Date
PL367702A1 true PL367702A1 (pl) 2005-03-07
PL206118B1 PL206118B1 (pl) 2010-07-30

Family

ID=27402954

Family Applications (1)

Application Number Title Priority Date Filing Date
PL367702A PL206118B1 (pl) 2001-03-23 2002-03-22 Kombinacja farmaceutyczna wykazująca synergizm terapeutyczny in vivo w leczeniu chorób nowotworowych

Country Status (33)

Country Link
US (2) US20020182204A1 (pl)
EP (1) EP1372652B1 (pl)
JP (1) JP2004521140A (pl)
KR (1) KR100879712B1 (pl)
CN (1) CN1498107A (pl)
AR (1) AR034222A1 (pl)
AT (1) ATE395917T1 (pl)
AU (1) AU2002312815B2 (pl)
BR (1) BR0208221A (pl)
CA (1) CA2441441C (pl)
CY (1) CY1110449T1 (pl)
CZ (1) CZ301423B6 (pl)
DE (1) DE60226710D1 (pl)
DK (1) DK1372652T3 (pl)
EA (1) EA007815B1 (pl)
ES (1) ES2305253T3 (pl)
HR (1) HRPK20030766B3 (pl)
HU (1) HU229258B1 (pl)
IL (2) IL158058A0 (pl)
ME (1) MEP16408A (pl)
MX (1) MXPA03007743A (pl)
NO (1) NO332441B1 (pl)
NZ (1) NZ527655A (pl)
PE (1) PE20020907A1 (pl)
PL (1) PL206118B1 (pl)
PT (1) PT1372652E (pl)
RS (1) RS50681B (pl)
SI (1) SI1372652T1 (pl)
SK (1) SK287481B6 (pl)
TW (1) TWI355935B (pl)
UY (1) UY27220A1 (pl)
WO (1) WO2002076484A2 (pl)
ZA (1) ZA200307381B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003217982A1 (en) * 2002-03-06 2003-09-22 The Medical Research And Education Trust Botanical extract compositions with anti-cancer or phytoestrogenic activity comprising wogonin, isoliquiritigenin and/or coumestrol
WO2004035034A2 (en) * 2002-10-16 2004-04-29 Ilex Products, Inc. Clofarabine and taxane chemotherapy combination
EP1558242B1 (en) * 2002-11-06 2008-12-24 Cyclacel Limited Combination comprising docetaxel and a cdk inhibitor
WO2007090794A1 (en) * 2006-02-10 2007-08-16 Nerviano Medical Sciences S.R.L. Combinations comprising a cdk inhibitor and a growth factor antibody or anti-mitotic
MX2013005661A (es) * 2010-11-19 2013-09-13 Piramal Entpr Ltd Combinacion farmaceutica de paclitaxel y un inhibidor cdk (quinasa dependiente de ciclina).
SI2694056T1 (sl) * 2011-04-01 2019-12-31 Astrazeneca Ab Terapevtsko zdravljenje
PL2785349T5 (pl) 2011-11-30 2023-01-30 Astrazeneca Ab Kombinacja do leczenia nowotworu
AU2013204533B2 (en) 2012-04-17 2017-02-02 Astrazeneca Ab Crystalline forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
FR2697752B1 (fr) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
EP0888458A4 (en) * 1996-02-20 2004-05-06 Sloan Kettering Institutefor C COMBINATION OF PROTEIN KINASE C INHIBITORS AND THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER

Also Published As

Publication number Publication date
AU2002312815B2 (en) 2006-08-24
MEP16408A (en) 2010-10-10
CA2441441C (en) 2009-05-26
HRPK20030766B3 (en) 2006-11-30
CZ20032551A3 (en) 2004-07-14
JP2004521140A (ja) 2004-07-15
DK1372652T3 (da) 2008-09-22
HUP0303589A2 (hu) 2004-03-01
PT1372652E (pt) 2008-07-24
RS50681B (sr) 2010-06-30
NZ527655A (en) 2006-03-31
PE20020907A1 (es) 2002-12-19
NO20034124L (no) 2003-09-16
HU229258B1 (en) 2013-10-28
MXPA03007743A (es) 2004-11-12
EP1372652A2 (en) 2004-01-02
NO20034124D0 (no) 2003-09-16
HRP20030766A2 (en) 2005-06-30
CZ301423B6 (cs) 2010-02-24
IL158058A0 (en) 2004-03-28
WO2002076484A2 (en) 2002-10-03
SK11692003A3 (sk) 2004-03-02
ATE395917T1 (de) 2008-06-15
WO2002076484A3 (en) 2003-01-03
TWI355935B (en) 2012-01-11
CN1498107A (zh) 2004-05-19
KR100879712B1 (ko) 2009-01-22
EP1372652B1 (en) 2008-05-21
HUP0303589A3 (en) 2007-05-02
IL158058A (en) 2010-02-17
ZA200307381B (en) 2005-03-30
YU69503A (sh) 2006-08-17
SK287481B6 (sk) 2010-11-08
US20060128640A1 (en) 2006-06-15
ES2305253T3 (es) 2008-11-01
CY1110449T1 (el) 2015-04-29
AR034222A1 (es) 2004-02-04
DE60226710D1 (de) 2008-07-03
UY27220A1 (es) 2002-09-30
BR0208221A (pt) 2004-03-02
US20020182204A1 (en) 2002-12-05
EA007815B1 (ru) 2007-02-27
SI1372652T1 (sl) 2008-10-31
CA2441441A1 (en) 2002-10-03
EA200301053A1 (ru) 2004-02-26
PL206118B1 (pl) 2010-07-30
NO332441B1 (no) 2012-09-17
KR20030086318A (ko) 2003-11-07

Similar Documents

Publication Publication Date Title
MXPA03006420A (es) Diaminotiazoles.
SG111920A1 (en) Authentication of electronic documents
AU2002332749A1 (en) Package with integrated inductor and/or capacitor
GB0121789D0 (en) Electronic paymetn authorisation
EP1390052A4 (en) INHIBITION OF JUN KINASE
HK1069385A1 (en) Heterocyclic compound and medicinal use thereof
EP1258893A4 (en) ULTRAMINIC CAPACITOR
TWI315982B (en) Combinations comprising epothilones and pharmaceutical uses thereof
PL367702A1 (pl) Kombinacja taksanu i cyklino-zależnej kinazy
GB0123657D0 (en) Worktool
GB0111891D0 (en) Personal hoverplane having four tiltmotors
HUP0500734A3 (en) Use of 2-alkoxyphenyl-substituted imidazotriazinones
GB0126889D0 (en) Compounds and their uses
IL158239A0 (en) Zonisamide intermediate and synthesis
EP1392317A4 (en) SUBSTITUTED 1-BENZAZEPINE AND DERIVATIVES THEREOF
EP1381061A4 (en) INDUCTANCE ELEMENT AND HOUSING
GB0115234D0 (en) Electronic authorisation
HUP0401162A3 (en) Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives
IL161608A0 (en) Synthesis of 2-aralkoxyadenosines and 2-alkoxyadenosines
EP1367123A4 (en) NEUROTONIN AND ITS USE
EP1421101A4 (en) P-GLYCOPROTEINS AND THEIR USES
IL156839A0 (en) Use of chromanes
ZA200305379B (en) Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase.
HU0104370D0 (en) Honeyed schnaps of oerseg
CA91419S (en) A set of furniture

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20140322